Clinitech Laboratory Ltd (544220)
Latest quarterly results (H2 FY26)
In its latest reported quarter, H2 FY26, Clinitech Laboratory's revenue was ₹4.4 Cr (+6.0% year on year, -13.2% on the previous half-year), and net profit ₹0.1 Cr (-29.4% year on year); the operating margin was 10.2%.
| H2 FY26 (₹ Cr) | Value | YoY vs H2 FY25 | vs prev. half |
|---|---|---|---|
| Revenue | ₹4.4 | +6.0% | -13.2% |
| Operating profit | ₹0.5 | +60.7% | -16.7% |
| Net profit | ₹0.1 | -29.4% | -60.0% |
| EPS (₹) | 0.53 | -28.4% | -59.5% |
| Operating margin | 10.2% | — | — |
📢 Recent Corporate Announcements
Clinitech Laboratory Limited has released the notice for its 16th Annual General Meeting (AGM), scheduled for September 24, 2026, via Video Conferencing. The company's Register of Members and Share Transfer Books will remain closed from September 18 to September 24, 2026. The Annual Report highlights FY26 consolidated profit attributable to shareholders of Rs 41.79 Lakhs with a Basic EPS of Rs 1.83. In FY26, the company expanded operations across its 50+ branches and incorporated two new subsidiaries: Medicarenx Multispeciality Hospital and Analog IVD Solutions.
- 16th Annual General Meeting to be held on Thursday, September 24, 2026 at 11:30 AM IST via VC/OAVM
- Book closure period set from Friday, September 18, 2026 to Thursday, September 24, 2026
- Consolidated FY26 profit attributable to equity shareholders reported at Rs 41.79 Lakhs compared to Rs 39.47 Lakhs in FY25
- Consolidated Basic EPS for FY26 stood at Rs 1.83 on a weighted average base of 22,82,400 equity shares
- Company incorporated two new subsidiaries during FY26: Medicarenx Multispeciality Hospital Pvt Ltd and Analog IVD Solutions Pvt Ltd
Clinitech Laboratory Limited has announced that its 16th Annual General Meeting (AGM) will be held on Thursday, September 24, 2026, at 11:30 AM IST via video conferencing. The share transfer books and Register of Members will remain closed from September 18, 2026, to September 24, 2026. The cut-off date for e-voting eligibility has been fixed as September 17, 2026. Remote e-voting will run from September 21, 2026 (9:00 AM IST) to September 23, 2026 (5:00 PM IST).
- 16th AGM scheduled for September 24, 2026, at 11:30 AM IST via video conferencing
- Book closure period set from September 18, 2026, to September 24, 2026
- E-voting cut-off date fixed for September 17, 2026
- Remote e-voting window open from September 21, 2026 (9:00 AM) to September 23, 2026 (5:00 PM)
Clinitech Laboratory Ltd has published its Annual Report for FY 2025-26 and scheduled its 16th Annual General Meeting for September 24, 2026. For FY26, the company posted a consolidated profit after tax of Rs 41.79 lakhs with a diluted EPS of Rs 1.83. Management highlighted expansion across 50+ branches and diversification via two new subsidiaries, Medicarenx Multispeciality Hospital and Analog IVD Solutions. The register of members will remain closed from September 18 to September 24, 2026.
- 16th AGM scheduled for September 24, 2026, with share transfer book closure from September 18 to September 24, 2026
- Consolidated FY26 profit after tax stood at Rs 41.79 lakhs compared to Rs 39.47 lakhs in the previous period
- Basic and diluted EPS recorded at Rs 1.83 on a weighted average equity share base of 22,82,400 shares
- Active network covers 50+ centres alongside entry into hospital operations and IVD solutions via new subsidiaries
Clinitech Laboratory Limited conducted its Board meeting on August 17, 2026, approving standard corporate governance matters. The Board approved the Board's Report for FY 2025-26, finalized the notice and book closure dates for the upcoming 16th Annual General Meeting (AGM), and approved the reappointment of a director retiring by rotation. Additionally, Mr. Deep Shukla was appointed as the scrutinizer for the AGM voting process. The meeting lasted 18 minutes, from 11:30 AM to 11:48 AM IST.
- Approved Board's Report along with annexures for FY 2025-26
- Convened the 16th Annual General Meeting (AGM) and finalized book closure dates
- Approved the appointment of a director retiring by rotation
- Appointed Mr. Deep Shukla, Practising Company Secretary, as scrutinizer for voting
- Board meeting concluded in 18 minutes on August 17, 2026 (11:30 AM to 11:48 AM IST)
Clinitech Laboratory has scheduled a board meeting for August 17, 2026, to address routine administrative and governance matters. The board will consider the approval of the annual report for FY 2025-26, during which the company recorded a revenue of ₹9.48 Cr and a net profit of ₹0.42 Cr. Additionally, the meeting will finalize the notice for the 16th Annual General Meeting (AGM) and set book closure dates. This is a standard procedural filing required for listed entities to conclude their annual reporting cycle.
- Board meeting scheduled for August 17, 2026, at 11:30 A.M. IST via video conferencing.
- Agenda includes approval of the Board's report and annexures for the financial year 2025-26.
- Finalization of the 16th Annual General Meeting (AGM) date, time, venue, and book closure dates.
- Appointment of Mr. Deep Shukla, Practising Company Secretary, as the scrutinizer for the voting process.
- Consideration of director retirement by rotation as per statutory requirements.
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
